A team of scientists and surgeons has for the first time validated a safe surgical access to the central core of the human cochlea, a hollow, spiral-shaped bone found in the inner ear which plays a key role in the sense of hearing.
8.11.2022 - An international research coalition has verified safe surgical access to the central core of the human cochlea for the very first time. The team of surgeons and scientists from the UK, Sweden and Canada, funded by Rinri Therapeutics, has confirmed secure surgical access to the central core of the human cochlea. The research is critical to the first in-human trials of new cell, gene and
Rinri Therapeutics Appoints Experienced Life Science Executive Nick Higgins as Chairman
Extensive private and public company corporate development track record
Significant expertise in cell and gene therapy
News provided by
Share this article
Share this article
SHEFFIELD, England, Feb. 1, 2021 /PRNewswire/ Rinri Therapeutics, a biotechnology company developing a novel cell-based therapy to restore hearing, today announces the appointment of Nick Higgins as Chairman of the Board. He takes over from Dr Erica Whittaker who has served as Chair since the creation of Rinri Therapeutics.
Nick s career spans over 35 years in the life science industry during which he gained extensive knowledge of UK and US markets in both private and public sectors. Nick was the former Chief Executive Officer (CEO) of Intercytex Group plc, a company focused on the development and manufacturing of cell therapy products which was subsequently sold through a series of asset sales. He also served as Chi